These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26588898)

  • 1. HIV-1 functional cure: will the dream come true?
    Liu C; Ma X; Liu B; Chen C; Zhang H
    BMC Med; 2015 Nov; 13():284. PubMed ID: 26588898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding a cure for HIV: will it ever be achievable?
    Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
    J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
    Chou TC; Maggirwar NS; Marsden MD
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latency reversal and viral clearance to cure HIV-1.
    Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
    Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing.
    Thorlund K; Horwitz MS; Fife BT; Lester R; Cameron DW
    BMC Infect Dis; 2017 Aug; 17(1):595. PubMed ID: 28851294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.
    Hayashi T; Jean M; Huang H; Simpson S; Santoso NG; Zhu J
    Antiviral Res; 2017 Oct; 146():76-85. PubMed ID: 28842263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current views on HIV-1 latency, persistence, and cure.
    Melkova Z; Shankaran P; Madlenakova M; Bodor J
    Folia Microbiol (Praha); 2017 Jan; 62(1):73-87. PubMed ID: 27709447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
    Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
    J Virol; 2017 May; 91(9):. PubMed ID: 28202759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Between a shock and a hard place: challenges and developments in HIV latency reversal.
    Zerbato JM; Purves HV; Lewin SR; Rasmussen TA
    Curr Opin Virol; 2019 Oct; 38():1-9. PubMed ID: 31048093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.
    Battistini A; Sgarbanti M
    Viruses; 2014 Apr; 6(4):1715-58. PubMed ID: 24736215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the way to find a cure: Purging latent HIV-1 reservoirs.
    Schwartz C; Bouchat S; Marban C; Gautier V; Van Lint C; Rohr O; Le Douce V
    Biochem Pharmacol; 2017 Dec; 146():10-22. PubMed ID: 28687465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection.
    Matsuda K; Maeda K
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.